Managing Recurrent Clostridioides Difficile Infection: Advancing the Science of Microbiome-Based Therapies

Complimentary breakfast provided!

Join a panel of three expert clinicians as they discuss new and emerging microbiome-based therapies for preventing recurrent Clostridioides difficile infection (rCDI) and how these agents may substantially improve patient quality of life. Earn 1.5 AMA PRA Category 1 Credits™ or 1.5 Accreditation Council for Pharmacy Education (ACPE) contact hours.

Statement of Need/Program Overview

Clostridioides difficile infection (CDI) is associated with a profound burden on patients. Several key risk factors for recurrent CDI (rCDI) have been identified (eg, antibiotic use, advanced age, prolonged hospital length of stay). The pathophysiologic processes in rCDI, including alterations in the gut microbiota, are complex, and selecting therapy for patients with rCDI is challenging. Novel microbiota-restoration therapies for rCDI treatment are recent additions to the market; clinicians require current information on the safety and efficacy of these agents and others that are in late-stage development.

Target Audience

The educational design of this activity addresses the needs of gastroenterologists, infectious disease specialists, and hospital/health-system pharmacists. Primary care physicians, nurse practitioners, physician assistants, and other clinicians involved in the management of rCDI will also benefit from participation and are encouraged to attend.

Educational Objectives

After completing the activity, clinicians should be able to:

1. Recognize the substantial health burdens associated with rCDI.
2. Describe the pathogenesis of rCDI, including the role of alterations in the intestinal microbiota.
3. Discuss antibiotic treatment strategies to optimize the management of rCDI.
4. Evaluate the most up-to-date clinical trial data for new and emerging microbiota restoration therapies for rCDI treatment.

Program Agenda

Duration	Topic
5:00 - 5:30 AM	Registration
5:30 – 6:00 AM	Breakfast
6:00 - 6:05 AM	Welcome and pre-test
6:05 – 6:20 AM	Role of the microbiome in rCDI
6:20 – 6:25 AM	Case discussion
6:25 – 6:40 AM	Selecting antibiotic treatment for rCDI
6:40 – 6:45 AM	Case discussion
6:45 – 7:05 AM	New and emerging microbiome-based biotherapies for rCDI
7:05 – 7:15 AM	Case discussion
7:15 – 7:20 AM	Post-test 3
7:20 - 7:30 AM	Q&A
7:30 AM	Adjourn

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Applied Clinical Education (ACE). Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Accreditation Statement

Global is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education with Commendation.

Credit Designation

Global designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the ACPE. (Universal Activity Number - 0530-9999-23-060-L01-P)
This is a knowledge-based activity.

Global Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Instructions to Receive Credit

To receive credit, participants must participate in the activity and complete the evaluation.

CME certificates will be sent via email to those successfully completing the activity. For ACPE learners, credit will be uploaded within 30 days of completion to CPE Monitor.

Fee Information and Refund/Cancellation Policy

There is no fee for this educational activity.

Disclosures of Relevant Financial Relationships

Global adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:

The planners and managers have the following relevant financial relationships with ineligible companies:

• The planners and managers at Global have no relevant financial relationships to disclose.
• The planners and managers at ACE have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and ACE do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Americans with Disabilities Act

Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Nicole Falco before the live event at (815) 861-9069 or by email at nicole@mymededco.com.

ACCME: This activity is jointly provided by Global Education Group and Applied Clinical Education.

ACPE: This activity is jointly provided by Global Education Group and Applied Clinical Education.

This activity is supported by an educational grant from Ferring Pharmaceuticals, Inc.

This event is neither sponsored by nor endorsed by ACG.